Finer nuances of clinical study agreements for research trials.
作者信息
Nayak Barun Kumar
出版信息
Indian J Ophthalmol. 2008 Jul-Aug;56(4):267-8. doi: 10.4103/0301-4738.41409.
Abstract
摘要
相似文献
1
Finer nuances of clinical study agreements for research trials.研究试验临床研究协议的细微差别。
Indian J Ophthalmol. 2008 Jul-Aug;56(4):267-8. doi: 10.4103/0301-4738.41409.
2
Industry-sponsored clinical research: a broken system.行业资助的临床研究：一个漏洞百出的体系。
JAMA. 2008 Sep 3;300(9):1069-71. doi: 10.1001/jama.300.9.1069.
3
New developments in managing physician-industry relationships.管理医生与产业界关系的新进展。
JAMA. 2008 Sep 3;300(9):1067-9. doi: 10.1001/jama.300.9.1067.
4
Conflicts of interest with the health industry.与健康产业的利益冲突。
Pain Med. 2006 Sep-Oct;7(5):463-5. doi: 10.1111/j.1526-4637.2006.00215_3.x.
5
Gag clauses in clinical-trial agreements.临床试验协议中的保密条款。
N Engl J Med. 2005 May 26;352(21):2160-2. doi: 10.1056/NEJMp048353.
6
Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.行业对学术合作有不当影响，保障措施需要加强：白大褂……戴的是哪顶帽子。
Surv Ophthalmol. 2014 May-Jun;59(3):346-8. doi: 10.1016/j.survophthal.2013.06.006. Epub 2014 Feb 6.
7
Relationships Between Academic Medicine Leaders and Industry-Time for Another Look?学术医学领袖与行业之间的关系——是否需要重新审视？
JAMA. 2020 Nov 10;324(18):1833-1834. doi: 10.1001/jama.2020.21021.
8
Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.利益冲突还是富有成效的合作？制药行业与学术界的关系及其对头痛医学的影响。
Headache. 2006 Jul-Aug;46(7):1181-5. doi: 10.1111/j.1526-4610.2006.00508.x.
9
NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.神经中枢：随着许多学术医疗中心进行自查，美国监察长办公室就国立卫生研究院对利益冲突监督不力发出警告。
Ann Neurol. 2010 Mar;67(3):A7-A10. doi: 10.1002/ana.22026.
10
Collaborating with industry--choices for the academic medical center.与产业界合作——学术医疗中心的选择
N Engl J Med. 2002 Oct 24;347(17):1371-5. doi: 10.1056/NEJMsb021319.
引用本文的文献
1
Ophthalmic research and publication in India: where do we stand?印度的眼科研究与出版物：我们处于什么位置？
Indian J Ophthalmol. 2010 Jul-Aug;58(4):273-4. doi: 10.4103/0301-4738.64115.
本文引用的文献
1
Conflict of interest in biomedical publications.生物医学出版物中的利益冲突。
Indian J Ophthalmol. 2007 Nov-Dec;55(6):409-10. doi: 10.4103/0301-4738.36471.
2
Academic medical centers' standards for clinical-trial agreements with industry.学术医疗中心与行业签订临床试验协议的标准。
N Engl J Med. 2005 May 26;352(21):2202-10. doi: 10.1056/NEJMsa044115.
3
Institutional ethics review of clinical study agreements.临床研究协议的机构伦理审查。
J Med Ethics. 2004 Feb;30(1):30-4. doi: 10.1136/jme.2003.005199.
4
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.一项关于医学院校与行业赞助商之间临床试验协议条款的全国性调查。
N Engl J Med. 2002 Oct 24;347(17):1335-41. doi: 10.1056/NEJMsa020349.
5
Working with the private sector: the need for institutional guidelines.与私营部门合作：制定机构指南的必要性。
BMJ. 2002 Aug 24;325(7361):432-5. doi: 10.1136/bmj.325.7361.432.
6
Between the lines: navigating the uncharted territory of industry-sponsored research.字里行间：探索行业资助研究的未知领域
Health Aff (Millwood). 2002 Mar-Apr;21(2):235-42. doi: 10.1377/hlthaff.21.2.235.
7
Sponsorship, authorship, and accountability.赞助、作者身份及责任。
N Engl J Med. 2001 Sep 13;345(11):825-6; discussion 826-7. doi: 10.1056/NEJMed010093.
8
Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.临床试验申办者的社会责任。缺乏商业回报并非终止试验的正当理由。
BMJ. 2001 Mar 10;322(7286):569-70. doi: 10.1136/bmj.322.7286.569.
9
Scientific harassment by pharmaceutical companies: time to stop.制药公司的科学骚扰：是时候停止了。
CMAJ. 2000 Jan 25;162(2):212-3.
10
Legal issues surrounding privately funded research cause furore in Toronto.围绕私人资助研究的法律问题在多伦多引发了轩然大波。
CMAJ. 1998 Oct 20;159(8):983-6.
Zotero 插件